A detailed history of Detalus Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Detalus Advisors, LLC holds 9,682 shares of PFE stock, worth $276,227. This represents 0.1% of its overall portfolio holdings.

Number of Shares
9,682
Previous 25,044 61.34%
Holding current value
$276,227
Previous $700,000 60.0%
% of portfolio
0.1%
Previous 0.25%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $425,527 - $482,213
-15,362 Reduced 61.34%
9,682 $280,000
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $4,950 - $5,801
-196 Reduced 0.78%
25,044 $700,000
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $6,265 - $7,194
242 Added 0.97%
25,240 $700,000
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $144,734 - $187,993
-5,539 Reduced 18.14%
24,998 $719,000
Q3 2023

Oct 26, 2023

SELL
$32.09 - $37.51 $4,460 - $5,213
-139 Reduced 0.45%
30,537 $1.01 Million
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $61,801 - $71,502
-1,711 Reduced 5.28%
30,676 $1.13 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $3,426 - $4,461
87 Added 0.27%
32,387 $1.32 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $27,972 - $36,515
-670 Reduced 2.03%
32,300 $1.66 Million
Q3 2022

Nov 04, 2022

BUY
$43.76 - $53.42 $1,837 - $2,243
42 Added 0.13%
32,970 $1.44 Million
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $12,376 - $14,675
-266 Reduced 0.8%
32,928 $1.73 Million
Q1 2022

Apr 25, 2022

SELL
$45.75 - $56.69 $125,080 - $154,990
-2,734 Reduced 7.61%
33,194 $1.72 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $21,982 - $32,585
-532 Reduced 1.46%
35,928 $2.12 Million
Q3 2021

Oct 20, 2021

BUY
$39.25 - $50.42 $129,917 - $166,890
3,310 Added 9.98%
36,460 $1.57 Million
Q2 2021

Jul 14, 2021

BUY
$35.91 - $40.68 $208,888 - $236,635
5,817 Added 21.28%
33,150 $1.3 Million
Q1 2021

Apr 15, 2021

BUY
$33.49 - $37.77 $9,276 - $10,462
277 Added 1.02%
27,333 $990,000
Q4 2020

Jan 19, 2021

SELL
$33.47 - $42.56 $23,931 - $30,430
-715 Reduced 2.57%
27,056 $996,000
Q3 2020

Nov 18, 2020

BUY
$31.75 - $37.25 $11,239 - $13,186
354 Added 1.29%
27,771 $1.02 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $54,577 - $66,210
1,812 Added 7.08%
27,417 $897,000
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $129,771 - $185,414
4,801 Added 23.08%
25,605 $836,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $684,867 - $777,237
20,804 New
20,804 $815,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Detalus Advisors, LLC Portfolio

Follow Detalus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.